ZCA
ABBV icon

Zeke Capital Advisors’s AbbVie ABBV Stock Holding History

Zeke Capital Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$1.93M Buy
11,916
+927
+8% +$142K 0.13% 76
2022
Q3 		$1.48M Sell
10,989
-18
-0.2% -$2.58K 0.11% 95
2022
Q2 		$1.69M Buy
11,007
+315
+3% +$48.1K 0.11% 92
2022
Q1 		$1.73M Buy
10,692
+9,018
+539% +$1.31M 0.09% 99
2021
Q4 		$227K Buy
+1,674
New +$198K 0.01% 266
2020
Q2 		– Sell
-8,730
Closed -$665K – 216
2020
Q1 		$665K Sell
8,730
-18,004
-67% -$1.53M 0.19% 69
2019
Q4 		$2.37M Buy
26,734
+1,281
+5% +$106K 0.2% 97
2019
Q3 		$1.93M Sell
25,453
-8,929
-26% -$612K 0.17% 102
2019
Q2 		$2.5M Sell
34,382
-914
-3% -$71.8K 0.24% 85
2019
Q1 		$2.84M Buy
35,296
+4,951
+16% +$405K 0.26% 77
2018
Q4 		$2.8M Buy
30,345
+8,260
+37% +$726K 0.27% 75
2018
Q3 		$2.09M Buy
22,085
+410
+2% +$38.9K 0.17% 91
2018
Q2 		$2.01M Sell
21,675
-12,540
-37% -$1.22M 0.19% 92
2018
Q1 		$3.24M Buy
34,215
+3,649
+12% +$401K 0.3% 62
2017
Q4 		$2.96M Buy
30,566
+5,073
+20% +$478K 0.31% 58
2017
Q3 		$2.27M Buy
25,493
+11,626
+84% +$885K 0.31% 57
2017
Q2 		$1M Buy
13,867
+2,883
+26% +$194K 0.19% 68
2017
Q1 		$716K Buy
10,984
+681
+7% +$42.8K 0.15% 79
2016
Q4 		$645K Buy
10,303
+4,529
+78% +$276K 0.17% 70
2016
Q3 		$353K Buy
+5,774
New +$374K 0.16% 49

Other funds holding ABBV

AWA
Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Zeke Capital Advisors's ABBV Position: Q4 2022 in Review

Zeke Capital Advisors increased its AbbVie (ABBV) stake by 8.4% in Q4 2022, buying an estimated $142K and bringing the position to 11,916 shares worth $1.93M. The position accounts for 0.13% of the portfolio, ranked #76.

Zeke Capital Advisors first reported a position in ABBV in Q3 2016 and has held it in 20 quarters since. The position peaked at $3.24M in Q1 2018. 3,167 funds tracked by Wall St. Rank hold ABBV as of Q4 2022.

  • Zeke Capital Advisors held 11,916 shares of AbbVie worth $1.93M as of Q4 2022.
  • Zeke Capital Advisors bought 927 AbbVie shares in Q4 2022, an estimated $142K.
  • AbbVie made up 0.13% of Zeke Capital Advisors's portfolio in Q4 2022, its #76 holding.
  • Zeke Capital Advisors first reported a position in AbbVie in Q3 2016 and has held it in 20 quarters since.
  • Zeke Capital Advisors's AbbVie position peaked at $3.24M in Q1 2018.
  • 3,167 funds tracked by Wall St. Rank held AbbVie as of Q4 2022.

Based on Zeke Capital Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.